Design Therapeutics, Inc. (DSGN)
Data as of , from SEC Form 4 filings.
See up to 3 months of DSGN. The 7-day demo opens the 1M and 3M ranges and puts DSGN on your watchlist.
Start 7-day demoLatest DSGN insider trades
About Design Therapeutics, Inc. (DSGN)
Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its pipeline includes Friedreich Ataxia, FECD, DM1, and Huntington's Disease. The company operates in one operating and reportable segment focused on utilizing the company's proprietary GeneTAC platform to design and develop therapeutic candidates for inherited diseases driven by nucleotide repeat expansion.
- CARLSBAD, CA
- 55
- 2021
- XNAS
DSGN Form 4 activity by transaction type, last 90 days
No Form 4 activity for DSGN in the last 90 days.
DSGN insider transactions (Form 4)
1310 Form 4 filings on record, the earliest from Dec 19, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Simeon George | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| John P. Schmid | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Rodney W. Lappe | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Justin D. Gover | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
 David Shapiro | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| Heather A. Berger | Grant or award | Stock Option (right to buy) | 30,000 | $0.00 | - | |
| David Shapiro | Grant or award | Stock option (right to buy) | 60,000 | $0.00 | - | |
| David Shapiro | Grant or award | Stock option (right to buy) | 7,500 | $0.00 | - | |
| Justin D. Gover | Grant or award | Stock option (right to buy) | 30,000 | $0.00 | - | |
| Justin D. Gover | Grant or award | Stock option (right to buy) | 15,833 | $0.00 | - | |
| Arsani William | Open-market sale | Common Stock | 345,000 | $5.25 | $1.81M | |
| Arsani William | Open-market sale | Common Stock | 217,627 | $5.25 | $1.14M | |
| Deepa Prasad | Open-market sale | Common Stock | 3,806 | $6.27 | $24K |
DSGN insider trading FAQ
What is the latest insider trade for DSGN?
Design Therapeutics, Inc. (DSGN) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-11. The full record for DSGN runs to 10 Form 4 filings, the earliest from 2024-12-19. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying DSGN stock?
No insider purchases of DSGN were filed in the last 90 days.
How many insiders are selling DSGN stock?
No insider sales of DSGN were filed in the last 90 days. 3 sales are on record for this company.
Where can I see DSGN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects DSGN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Simeon George view on EDGAR
- - John P. Schmid view on EDGAR
- - Rodney W. Lappe view on EDGAR
- - Justin D. Gover view on EDGAR
- - David Shapiro view on EDGAR
- - Heather A. Berger view on EDGAR
- - David Shapiro view on EDGAR
- - Justin D. Gover view on EDGAR
- - Arsani William view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where DSGN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow DSGN with a 7-day demo
- DSGN on your watchlist
- Every DSGN Form 4 filing on record
- Up to 3 months of DSGN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
